KRAKOW, Poland, June 8, 2022 /PRNewswire/ — The AI-based system developed by Cardiomatics streamlines the work of cardiologists by supporting ECG interpretation. Now doctors at PZU Zdrowie (a Polish healthcare provider associated with the PZU Group – one of Central and Eastern Europe’s leading insurance companies) will be able to take advantage of its clinically proven accuracy.
The electrocardiogram (ECG) is the most common test used to assess heart health and detect dangerous and concerning heart rhythms, such as atrial fibrillation (AF) – the most common cardiac arrhythmia. The prevalence of AF has increased by 33% worldwide over the past 20 yearsand in Europe1-3% of the population suffers from this life-threatening disease.
Cardiomatics transforms cardiologist workflows by automating ECG analysis. The web-based application – certified as a CE Class II medical device – applies artificial intelligence algorithms to inspect the waves and intervals of ECG recordings to assess heart rate and detect any abnormalities. It then calculates all 12-lead ECG values and prepares a user-friendly report that perfectly summarizes the most important information and can be quickly and easily assimilated by the cardiologist.
Increase the screening rate to improve prevention and early diagnosis
The Polish company Cardiomatics has been refining the technology since 2018 and is now one of the leading providers of ECG analysis software. As one of the leading healthcare providers in PolandPZU Zdrowie recognized the high quality and accuracy of the Cardiomatics software and decided to include it in a pilot project at its healthcare facilities located across Poland Capital city.
“According to the Central Statistical Office of Poland (GUS), cardiovascular disease accounts for nearly half of all deaths in Poland. That’s why we want to further develop our cardiac diagnostic tools“says Oliwer Kubicki, board member of PZU Zdrowie. Kubicki is convinced that artificial intelligence can significantly streamline the work done by doctors, which, in turn, will bring benefits to their patients.”Accurate analysis facilitates optimal treatment results and shortens the time between diagnosis and medical intervention if a patient’s condition is alarming,“said Kubicki.
Algorithms trained for human precision
So far, the Cardiomatics software has examined more than 150,000 patients. This equates to roughly 20 billion heartbeats, far more than a doctor is able to analyze in a lifetime. Such a large data set helped Cardiomatics perfect the accuracy of the algorithm.
More than 1,000 doctors in 15 countries, including Swiss, Germanythe UK and Poland, already rely on the support of Cardiomatics software, which is perhaps unsurprising given that it is currently the fastest method available on the market. After the implementation process, where the data is collected, the overall duration of the ECG examination can be reduced up to 30 minutes.
Cardiomatics’ innovation is compatible with most ECG recorders available on the market. Built-in algorithms comply with ANSI/AAMI EC57:2012 and have been verified against MIT-BIH arrhythmia databases and clinical data.
“Cardiomatics and PZU Zdrowie share a common goal of using modern technologies to facilitate access to medical care. An equally important goal is to improve the workflow of healthcare professionals“says Rafał Samborski, Chairman of the Board of Cardiomatics.
“We are proud to start collaborating with PZU Zdrowie. It is a new stepping stone to the large-scale implementation of reliable and accurate AI algorithms for the benefit of cardiologists and patients.“, emphasizes Samborski.
PZU (Powszechny Zakład Ubezpieczeń SA) is Poland the oldest and largest listed insurance company and one of the leading insurance companies in central and Eastern Europe. It is also one of the largest financial institutions in Poland. PZU Zdrowie (Eng. PZU Health), part of PZU Group, is one of the Poland leading healthcare providers, with 130 healthcare facilities and 2,200 partner clinics in 600 cities, as well as its own network of medical imaging clinics and a telemedicine center.
Cardiomatic is a revolutionary cloud-based software that automates the analysis of ECG signals. It is a CE Class IIa medical device, and the effectiveness of its AI algorithms has been validated in clinical trials. The solution uses HIPAA-compliant global services that ensure security and accessibility from anywhere in the world.